Expanding Veterans’ Access to Emerging Treatments Act

This bill would require the Department of Veterans Affairs (VA) to set up a research program within 90 days to study new treatments for veterans with conditions such as anxiety, chronic pain, depression, PTSD, substance use disorders, and traumatic brain injury. The treatments listed include MDMA, psilocybin, ibogaine, ketamine, and other substances, as well as investigational drugs and medical devices like deep brain stimulation and hyperbaric oxygen therapy. The VA could run clinical trials and create a compassionate or extended access process so eligible veterans could join trials or be considered for these treatments. The VA would have to report to Congress within one year and review the program within two years, when it could extend or end it.

Full text and official record on Congress.gov

Sponsors

• Jack Bergman Republican sponsor
• 3 cosponsors